The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry

CONCLUSION: The patients without a second AF had significantly shorter overall survival. Our analysis suggests the importance of switching patients with an ineffective first AF therapy to a second AF therapy.PMID:38160169 | DOI:10.1016/j.arbres.2023.12.002

Source: Archivos de Bronconeumologia - December 30, 2023 Category: Respiratory Medicine Authors: Jakub Gregor Yochai Adir Martina Šterclová Nesrin Mogulkoc Mordechai R Kramer Martina Doubkov á Martina Pla čková Veronika M üller Michael Studnicka Monika Žurková Ladislav Lacina Katarzyna Lewandowska Vladim ír Bartoš Petra Ovesn á Ond řej M� Source Type: research